Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 116046

1.

Cyclin-Dependent Kinase 12, Immunity, and Prostate Cancer.

Antonarakis ES.

N Engl J Med. 2018 Sep 13;379(11):1087-1089. doi: 10.1056/NEJMcibr1808772. No abstract available.

PMID:
30207914
2.

Are localized prostate cancer biomarkers useful in the clinical practice?

Carneiro A, Priante Kayano P, Gomes Barbosa ÁR, Langer Wroclawski M, Ko Chen C, Cavlini GC, Reche GJ, Sanchez-Salas R, Tobias-Machado M, Sowalsky AG, Bianco B.

Tumour Biol. 2018 Sep;40(9):1010428318799255. doi: 10.1177/1010428318799255. Review.

PMID:
30204063
3.

Docetaxel-induced radiation recall dermatitis with atypical features: A case report.

Sakaguchi M, Maebayashi T, Aizawa T, Ishibashi N.

Medicine (Baltimore). 2018 Sep;97(36):e12209. doi: 10.1097/MD.0000000000012209.

4.
5.

Short interval of biopsy to robotic-assisted laparoscopic radical prostatectomy does not render any adverse effects on the perioperative outcomes.

He M, Li Y, Xiang Z, Sun LA, Zhu Y, Hu X, Guo J, Wang H.

Medicine (Baltimore). 2018 Sep;97(36):e11686. doi: 10.1097/MD.0000000000011686.

6.

A Combination of Findings Obtained from Pre- and Postoperative Imaging Predict Recovery of Urinary Continence After Non-nerve-sparing Laparoscopic Radical Prostatectomy.

Onishi T, Sekito S, Terabe T, Shibahara T.

Anticancer Res. 2018 Sep;38(9):5525-5530. doi: 10.21873/anticanres.12887.

PMID:
30194212
7.

Outcome of Patients with Metastatic Castration-resistant Prostate Cancer After PSA Progression with Abiraterone Acetate.

Hung SC, Wang SS, Li JR, Chen MC, Yang CK, Chen CS, Ho HC, Chiu KY, Cheng CL, Chang CH, Ou YC.

Anticancer Res. 2018 Sep;38(9):5429-5436. doi: 10.21873/anticanres.12874.

PMID:
30194199
8.

Single-centre Experience of Use of Radium 223 with Clinical Outcomes Based on Number of Cycles and Bone Marrow Toxicity.

Dadhania S, Alonzi R, Douglas S, Gogbashian A, Hughes R, Dalili D, Vasdev N, Adshead J, Lane T, Westbury C, Anyamene N, Ostler P, Hoskin P, Sharma A.

Anticancer Res. 2018 Sep;38(9):5423-5427. doi: 10.21873/anticanres.12873.

PMID:
30194198
9.

Seminal Cell Free DNA Concentration Levels Discriminate Between Prostate Cancer and Benign Prostatic Hyperplasia.

Ponti G, Maccaferri M, Micali S, Manfredini M, Milandri R, Bianchi G, Pellacani G, Kaleci S, Chester J, Conti A, Del Prete C, Tomasi A.

Anticancer Res. 2018 Sep;38(9):5121-5125. doi: 10.21873/anticanres.12833.

PMID:
30194158
10.

Identification of a Novel MicroRNA Panel Associated with Metastasis Following Radical Prostatectomy for Prostate Cancer.

Nam RK, Wallis CJD, Amemiya Y, Benatar T, Seth A.

Anticancer Res. 2018 Sep;38(9):5027-5034. doi: 10.21873/anticanres.12821.

PMID:
30194146
11.

Increased levels of serum miR-148a-3p are associated with prostate cancer.

Dybos SA, Flatberg A, Halgunset J, Viset T, Rolfseng T, Kvam S, Skogseth H.

APMIS. 2018 Sep;126(9):722-731. doi: 10.1111/apm.12880.

PMID:
30160020
12.

NOL8, the binding protein for beta-catenin, promoted the growth and migration of prostate cancer cells.

Gu S, Hou P, Liu K, Niu X, Wei B, Mao F, Xu Z.

Chem Biol Interact. 2018 Oct 1;294:40-47. doi: 10.1016/j.cbi.2018.08.019. Epub 2018 Aug 18.

PMID:
30125550
13.

Power of a Trial Investigating a Low-Intensity PSA-Based Screening Intervention-Reply.

Martin RM; CAP Trial Group.

JAMA. 2018 Aug 14;320(6):600-601. doi: 10.1001/jama.2018.7335. No abstract available.

PMID:
30120473
14.

Power of a Trial Investigating a Low-Intensity PSA-Based Screening Intervention.

Pinsky PF.

JAMA. 2018 Aug 14;320(6):600. doi: 10.1001/jama.2018.7327. No abstract available.

PMID:
30120468
15.

Enzyme-triggered self-assembly of gold nanoparticles for enhanced retention effects and photothermal therapy of prostate cancer.

Yang S, Yao D, Wang Y, Yang W, Zhang B, Wang D.

Chem Commun (Camb). 2018 Aug 28;54(70):9841-9844. doi: 10.1039/c8cc05136d.

PMID:
30110025
16.

The effects of urolithins on the response of prostate cancer cells to non-steroidal antiandrogen bicalutamide.

Stanisławska IJ, Piwowarski JP, Granica S, Kiss AK.

Phytomedicine. 2018 Jul 15;46:176-183. doi: 10.1016/j.phymed.2018.03.054. Epub 2018 Mar 21.

PMID:
30097116
17.

MRI-Targeted Biopsy for Prostate-Cancer Diagnosis.

Vickers A, Ehdaie B.

N Engl J Med. 2018 Aug 9;379(6):589. doi: 10.1056/NEJMc1807507. No abstract available.

PMID:
30091346
18.

MRI-Targeted Biopsy for Prostate-Cancer Diagnosis.

Martini A, Cumarasamy S, Tewari AK.

N Engl J Med. 2018 Aug 9;379(6):589. doi: 10.1056/NEJMc1807507. No abstract available.

PMID:
30091345
19.

MRI-Targeted Biopsy for Prostate-Cancer Diagnosis.

Kasivisvanathan V, Emberton M, Moore CM.

N Engl J Med. 2018 Aug 9;379(6):589-590. doi: 10.1056/NEJMc1807507. No abstract available.

20.

Post-Prostatectomy Radiation Therapy: Patient Selection, Timing, Imaging, and Therapy Intensification.

Robin TP, Maroni PD, Chin BB, La Rosa FG, Bernard B, Pugh TJ.

Oncology (Williston Park). 2018 Jul 15;32(7):360-3, 369, CV3. No abstract available.

Supplemental Content

Loading ...
Support Center